Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07140094 · ClinicalTrials.gov registry record · NA

Long-Covid-19 Alleviation Through Learning Mindfulness Study

A NA study of Long COVID and Post-Acute COVID-19 Syndrome, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT07140094: Recruiting NA study of Long COVID and Post-Acute COVID-19 Syndrome, sponsored by Columbia University.

NCT07140094 is a NA study of Long COVID and Post-Acute COVID-19 Syndrome that is actively recruiting participants, run by Columbia University. The registered enrollment target is 400 participants, below the 2,180-participant average among 50 other Long COVID trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07140094, a NA study of Long COVID and Post-Acute COVID-19 Syndrome, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

This research is being done to study a mindfulness intervention among people who have symptoms of Post-Acute Sequelae of SARS-CoV-2 infection (PASC), also known as Long COVID. Mindfulness is defined as paying attention to the present moment with non-judgment and acceptance. Here the investigators are studying whether a mindfulness intervention can help reduce stress, reduce Long COVID symptoms, and improve quality of life among people living with Long COVID. The mindfulness intervention is a series of recorded mindfulness sessions, which were created by the study team. People who decide to take part will be randomly assigned to receive the study mindfulness intervention immediately after joining the study or to receive the study mindfulness intervention 8 weeks after joining the study. All participants will continue their usual medical care. Participants will complete online surveys to measure symptoms over time. The study will last 6 months.

Primary Outcome

This is to compare the difference between both groups at Month 2. The PROMIS Global 10 is a health-related quality of life measure. Raw scores range from 4 to 20. A higher score indicates better health.

Interventions

  • BEHAVIORAL Structured mindfulness intervention

Study Locations (1)

New York

  • Columbia University - New York

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2024-05-21
Est. Completion 2027-11-21
Phase NA
Columbia University

958 total trials

What NCT07140094 shows while recruiting

NCT07140094 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 2,180-participant average among 50 other Long COVID trials with a reported enrollment target (82% lower).

The record links to 6 conditions, with Long COVID appearing as the primary indexed condition, and to 1 intervention - of which Structured mindfulness intervention is the first listed.

NCT07140094 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT07140094 about?

NCT07140094 is a clinical study titled "Long-Covid-19 Alleviation Through Learning Mindfulness Study". This research is being done to study a mindfulness intervention among people who have symptoms of Post-Acute Sequelae of SARS-CoV-2 infection (PASC), also known as Long COVID. Mindfulness is defined as paying attention to the present moment with non-judgment and acceptance. Here the investigators ar...

What is the current status of trial NCT07140094?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2024-05-21. Estimated completion is 2027-11-21.

What conditions does trial NCT07140094 study?

This clinical trial studies the following conditions: Long COVID, Post-Acute COVID-19 Syndrome, Long COVID-19, COVID Long-Haul, Post-Acute COVID-19.

What interventions are being tested in trial NCT07140094?

The interventions under investigation include: Structured mindfulness intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07140094?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07140094 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Long COVID

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07140094's enrollment target sits among peer trials

400 7th of 50 higher than 44 of 50 other Long COVID trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Long COVID trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07140094, the US trial registry maintained by the National Library of Medicine. NCT07140094 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.